JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia veraAmi B. Patel(University of Utah), Michael W. Deininger(Oregon Health & Science University)BloodOctober 14, 201910.1182/blood.2019001385Cited by 35SaveCiteExport RISWatch citationsRelated PapersIn vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit|Blood|2005|61Acute dasatinib exposure commits Bcr-Abl–dependent cells to apoptosis|Blood|2009|59Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-β Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib|Clinical Cancer Research|2006|26